S&P 5007,489.72▲0.7% Nasdaq25,373.85▲1.0% Dow52,485.03▲0.5% Russell 2K2,931.34▼0.5% 10-Yr4.75%+8bp VIX15.99−1.10 WTI$86.80▲3.8% Gold$4,098.60▼0.0% EUR/USD1.153▲0.5% BTC$62,930▼2.8% Nikkei61,867▲0.7%
At close · Fri, Jul 31, 2026
Daily Market Updates.

US Markets

Home›US Markets›Equities›Pharma stock targets growth after opioid specialist pr…

Pharma stock targets growth after opioid specialist profits jump 108%

Friday, July 31, 2026 · Written up by our desk · Equities

A pharma stock is in focus as it looks to benefit from a related opioid addiction specialist after that company reported profit gains of 108%, according to Yahoo Finance.

The coverage frames the move around the specialist's surge in profits and the potential impact on the pharma stock’s prospects.

← Newer storyExxon profit surge fails to lift shares, after Chevron better quarter

More like this

US MarketsIntel shares soar as Wells Fargo cites stronger AI and data center momentum
US MarketsAmazon stock rises on earnings amid growing cloud competition
US MarketsAmazon stock rises as earnings lift cloud momentum
US MarketsAmazon shares jump as Apple drops following latest earnings
US MarketsExxon profit surge fails to lift shares, after Chevron better quarter

Sources

Yahoo FinanceThis Pharma Stock Eyes Entry As Opioid Addiction Specialist's Profits Surge 108%

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.